The Finance Show

The Finance Show

News EN ↓ 8 episodes

The Finance Show is Belgium's go-to podcast for corporate finance news and career development. Every two weeks, we deliver the most important news in Belgium, and career insights for breaking into the industry. We also feature expert interviews with industry leaders, academics, and professionals who share their experiences and advice. Whether you're a student aspiring to work in investment banking, M&A, or corporate development, or a professional wanting to stay informed about what's happening in the market, The Finance Show is your one-stop for Belgian corporate finance.

Author

The Finance Show

Category

News

Podcast website

podcasters.spotify.com

Latest episode

Jun 9, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

Episode 7: UCB's $2.2B Deal, EQT Buys Back Desotec for €2B & UniCredit's €35B Hostile Bid for Commerzbank 09.06.2026

Welcome to the seventh episode of The Finance Show, Belgium's podcast for corporate finance news, insights, and career guidance. In this episode: Belgian deals: UCB strikes again, acquiring San Diego biotech Candid Therapeutics for up to $2.2 billion, the third major US deal in two months as Belgium's pharma giant deploys its post-debt war chest into next-generation immunology. EQT buys ba...

Episode 6: UCB's $1.15B US Acquisition, GBL's €500M BUKO Deal & China Blocks Meta-Manus 05.05.2026

Welcome to the sixth episode of The Finance Show, Belgium's podcast for corporate finance news, insights, and career guidance. In this episode: Belgian deals: UCB acquires US biotech Neurona Therapeutics for up to $1.15 billion, expanding its leadership in epilepsy with a cell therapy bet. GBL deploys another €500M to acquire a majority stake in Dutch traffic management specialist BUKO, execut...

Episode 5: Animalcare's €270M Takeover, Delvaux's €100M Rescue & Pershing Square's $64B UMG Bid 22.04.2026

Welcome to the fifth episode of The Finance Show, Belgium's podcast for corporate finance news, insights, and career guidance. In this episode: Belgian deals: Charterhouse Capital Partners launches a €270M takeover bid on Animalcare, the British veterinary pharmaceuticals company backed by Marc Coucke. Richemont injects €100.6M into its Belgian subsidiary Delvaux, converting debt into equity t...

Episode 4: Keyrock's $1.1B Unicorn, OpenUp's €20M, Elia's €2B RCF & SpaceX's $2T IPO 08.04.2026

Welcome to the fourth episode of The Finance Show, your briefing on Belgian and global corporate finance. In this episode: Belgian deals: Keyrock closes a Series C led by Standard Chartered at a $1.1 billion valuation, becoming Belgium's ninth unicorn. We cover the business model, the funding history, and what makes this raise remarkable in a difficult crypto market. Smartfin leads a €20M Seri...

Episode 3: Loop's €50M Debt Play, Belron's $40B IPO, Belgium's M&A League Tables & Private Credit's Warning Signs 23.03.2026

Welcome to the third episode of The Finance Show, your biweekly briefing on Belgian and global corporate finance. In this episode: Belgian deals: Loop Earplugs raises €50M through a masterclass in capital structure, debt over equity. Belron, the parent company of Carglass, is exploring a potential IPO at a valuation of up to $40 billion, what it means for D'Ieteren, where it lists, and why 202...

Episode 2: Aedifica's Merger, What's Cooking's Exit, Syndicate One's €22M Bet & The Warner Bros Finale 09.03.2026

Episode 2: Healthcare Merger, Belgian Delistings, VC Funding & a Hollywood Finale Welcome to the second episode of The Finance Show, your biweekly briefing on Belgian and global corporate finance. In this episode: Belgian deals: Aedifica secures 80% of Cofinimmo, paving the way for a €12B European healthcare real estate giant. What's Cooking's controlling families offer €88M to delist...

Episode 1: GBL's Healthcare Play, Agomab's Nasdaq Debut & The Battle for Warner Bros 23.02.2026

Episode 1: The Finance Show Launches Welcome to the first episode of The Finance Show, your biweekly briefing on Belgian and global corporate finance. In this episode: Belgian deals: GBL invests €500M in UK medtech Rayner as part of its healthcare pivot. John Cockerill raises €300M to fund defense and hydrogen expansion. Belgian biotech Agomab goes public on Nasdaq for $200M, choosing US markets o...

The Finance Show is coming 17.02.2026

The Finance Show is coming! The Finance Show is the one and only podcast dedicated to Belgian corporate finance. It has been created by students for students. If you're curious about the deals and trends shaping Belgium's economy or preparing for corporate finance interviews, this podcast is for you. Every two weeks, the podcast will break down the most important corporate finance news in...

Listen to the The Finance Show podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.